Therapeutic siRNA silencing in inflammatory monocytes in mice
Florian Leuschner(Harvard University), Partha Dutta(Harvard University), Rostic Gorbatov(Massachusetts General Hospital), Tatiana I. Novobrantseva(Alnylam Pharmaceuticals (United States)), Jessica Donahoe(Center for Systems Biology), Gabriel Courties(Center for Systems Biology), Kang Mi Lee(Massachusetts General Hospital), James I. Kim(Massachusetts General Hospital), James F. Markmann(Massachusetts General Hospital), Brett Marinelli(Harvard University), Peter Panizzi(Auburn University), Won Woo Lee(Seoul National University Bundang Hospital), Yoshiko Iwamoto(Center for Systems Biology), Stuart Milstein(Alnylam Pharmaceuticals (United States)), Hila Epstein-Barash(Alnylam Pharmaceuticals (United States)), William Cantley(Alnylam Pharmaceuticals (United States)), Jamie Wong(Alnylam Pharmaceuticals (United States)), Virna Cortez‐Retamozo(Center for Systems Biology), Andita Newton(Harvard University), Kevin T. Love(Massachusetts Institute of Technology), Peter Libby(Brigham and Women's Hospital), Mikäel J. Pittet(Harvard University), Filip K. Świrski(Center for Systems Biology), Victor Koteliansky(Alnylam Pharmaceuticals (United States)), Róbert Langer(Massachusetts Institute of Technology), Ralph Weissleder(Massachusetts General Hospital), Daniel G. Anderson(Harvard–MIT Division of Health Sciences and Technology), Matthias Nahrendorf(Massachusetts General Hospital)
Cited by 835Open Access